BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31437357)

  • 1. Recurrence predictability by various staging systems in 283 patients after thyroidectomy and radioactive iodine treated for papillary thyroid carcinoma.
    Yaniv D; Mizrachi A; Raz R; Tzelnick S; Feinmesser R; Hamzany Y; Vaisbuch Y; Hilly O
    Clin Otolaryngol; 2019 Nov; 44(6):1147-1152. PubMed ID: 31437357
    [No Abstract]   [Full Text] [Related]  

  • 2. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy.
    Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR
    Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioactive iodine does not improve overall survival for patients with aggressive variants of papillary thyroid carcinoma less than 2 cm.
    Holoubek SA; MacKinney EC; Khokar AM; Kuchta KM; Winchester DJ; Prinz RA; Moo-Young TA
    Surgery; 2022 Jan; 171(1):203-211. PubMed ID: 34384604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial.
    Dehbi HM; Mallick U; Wadsley J; Newbold K; Harmer C; Hackshaw A
    Lancet Diabetes Endocrinol; 2019 Jan; 7(1):44-51. PubMed ID: 30501974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of completion thyroidectomy followed by radioactive iodine ablation for patients with lymph node recurrence of papillary thyroid carcinoma.
    Saito Y; Matsuzu K; Sugino K; Takami H; Kitagawa W; Nagahama M; Ito K
    Surgery; 2019 Sep; 166(3):342-348. PubMed ID: 31128851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult Contralateral Lateral Lymph Node Metastases in Unilateral N1b Papillary Thyroid Carcinoma.
    Bohec H; Breuskin I; Hadoux J; Schlumberger M; Leboulleux S; Hartl DM
    World J Surg; 2019 Mar; 43(3):818-823. PubMed ID: 30465086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intermediate-Risk Papillary Thyroid Cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
    Llamas-Olier AE; Cuéllar DI; Buitrago G
    Thyroid; 2018 Oct; 28(10):1311-1317. PubMed ID: 30105948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose radioactive iodine therapy is associated with decreased risk of recurrence in high-risk papillary thyroid cancer.
    Gray KD; Bannani S; Caillard C; Amanat S; Ullmann TM; Romanov P; Brunaud L; Beninato T; Fahey TJ; Mirallie E; Zarnegar R
    Surgery; 2019 Jan; 165(1):37-43. PubMed ID: 30274732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of tumor size and focality with recurrence/persistence in papillary thyroid cancer patients treated with total thyroidectomy along with radioactive-iodine ablation and TSH suppression.
    Khan M; Syed AA; Khan AI; Hussain SR; Urooj N
    Updates Surg; 2018 Mar; 70(1):121-127. PubMed ID: 28550398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIFT-P: Are they indolent tumors? Results of a multi-institutional study.
    Chereau N; Greilsamer T; Mirallié E; Sadowski SM; Pusztaszeri M; Triponez F; Baud G; Pattou F; Christou N; Mathonnet M; Brunaud L; Santucci N; Goudet P; Guérin C; Sebag F; Donatini G; Kraimps JL; Tissier F; Lussey-Lepoutre C; Leenhardt L; Menegaux F
    Surgery; 2019 Jan; 165(1):12-16. PubMed ID: 30420090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrabony mandibular metastases caused by papillary thyroid carcinoma masquerading as a parotid swelling.
    Wareing J; Dawoud B; Power A; Sutton D
    Ann R Coll Surg Engl; 2021 Sep; 103(8):e264-e265. PubMed ID: 34464554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized Follow-Up Strategy for Patients with an Indeterminate Response to Initial Therapy for Papillary Thyroid Carcinoma.
    Oh HS; Ahn JH; Song E; Han JM; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
    Thyroid; 2019 Feb; 29(2):209-215. PubMed ID: 30384812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival is improved with total thyroidectomy and radiation for male patients and patients older than 55 with T2N0M0 Stage 1 classic papillary thyroid cancer.
    MacKinney EC; Kuchta KM; Winchester DJ; Khokar AM; Holoubek SA; Moo-Young TA; Prinz RA
    Surgery; 2022 Jan; 171(1):197-202. PubMed ID: 34666913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors for papillary thyroid cancer persistence and recurrence: a retrospective analysis with a 10-year follow-up cohort study.
    de Castro TP; Waissmann W; Simões TC; de Mello RC; Carvalho DP
    Clin Endocrinol (Oxf); 2016 Sep; 85(3):466-74. PubMed ID: 26834009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choroidal metastasis from papillary thyroid cancer: An unusual feature of a common disease.
    Fountas A; Tigas S; Giotaki Z; Tsatsoulis A; Kalogeropoulos CD
    Ann Endocrinol (Paris); 2017 Feb; 78(1):64-66. PubMed ID: 27887671
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical outcomes and risk stratification for papillary thyroid carcinoma presenting with distant metastasis before the era of tyrosine kinase inhibitors.
    Matsuzu K; Sugino K; Masudo K; Mori K; Ono R; Yamazaki H; Masaki C; Akaishi J; Kiyomi Yamada H; Tomoda C; Suzuki A; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Takami H; Ito K
    Endocr J; 2020 Aug; 67(8):869-876. PubMed ID: 32350192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level.
    Epstein S; McEachern R; Khot R; Padia S; Patrie JT; Itri JN
    J Ultrasound Med; 2018 Oct; 37(10):2325-2331. PubMed ID: 29498418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical prognostic index for recurrence of papillary thyroid carcinoma including intraoperative findings.
    Kim KM; Park JB; Bae KS; Kim CB; Kang DR; Kang SJ
    Endocr J; 2013; 60(3):291-7. PubMed ID: 23131897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
    Mazzaferri EL; Jhiang SM
    Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.